atorvastatin has been researched along with ticagrelor in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Butler, KA; Mitchell, PD; Teng, R | 1 |
| Ahmed, Z; Bajwa, A; Bhardwaj, B; Laster, SB; Magalski, A | 1 |
| Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Sartori, C; Suryapranata, H; Verdoia, M | 1 |
| Beavers, JC | 1 |
| Kerbel, T; Litschauer, B; Weisshaar, S; Wolzt, M | 1 |
| Danielak, D; Gorzycka, P; Główka, F; Karaźniewicz-Łada, M; Kruszyna, Ł | 1 |
| He, Y; Li, PB; Lin, QW; Liu, H; Su, WW; Wang, YG; Wu, H; Yan, ZH; Yao, HL; Zhang, WJ | 1 |
| Chen, Y; Hu, M; Wang, Y; Zhang, L | 1 |
1 review(s) available for atorvastatin and ticagrelor
| Article | Year |
|---|---|
Spontaneous coronary artery dissection: the management dilemma continues.
Topics: Adenosine; Adult; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Carbazoles; Carvedilol; Coronary Angiography; Coronary Vessel Anomalies; Diagnosis, Differential; Echocardiography; Electrocardiography; Female; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Propanolamines; Purinergic P2Y Receptor Antagonists; Ticagrelor; Vascular Diseases | 2015 |
2 trial(s) available for atorvastatin and ticagrelor
| Article | Year |
|---|---|
Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers.
Topics: Adenosine; Adult; Area Under Curve; Atorvastatin; Biotransformation; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Least-Squares Analysis; Linear Models; Male; Metabolic Clearance Rate; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Pyrroles; Simvastatin; Ticagrelor | 2013 |
Atorvastatin combined with ticagrelor prevent ischemia-reperfusion induced vascular endothelial dysfunction in healthy young males - A randomized, placebo-controlled, double-blinded study.
Topics: Acetylcholine; Adenosine; Adolescent; Adult; Atorvastatin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Purinergic P2Y Receptor Antagonists; Regional Blood Flow; Reperfusion Injury; Ticagrelor; Vasodilation; Young Adult | 2018 |
6 other study(ies) available for atorvastatin and ticagrelor
| Article | Year |
|---|---|
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy.
Topics: Adenosine; Aged; Aspirin; Atorvastatin; Chi-Square Distribution; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polypharmacy; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Ticagrelor; Ticlopidine; Treatment Outcome | 2015 |
Elevated Creatine Kinase due to Potential Drug Interaction With Ticagrelor and Atorvastatin.
Topics: Atorvastatin; Cardiac Catheterization; Clopidogrel; Creatine Kinase; Drug Interactions; Drug-Eluting Stents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticagrelor | 2019 |
Development of an LC-MS/MS method for simultaneous determination of ticagrelor and its active metabolite during concomitant treatment with atorvastatin.
Topics: Atorvastatin; Chromatography, Liquid; Humans; Limit of Detection; Linear Models; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Reproducibility of Results; Tandem Mass Spectrometry; Ticagrelor | 2019 |
Protective effects of Naoxintong capsule alone and in combination with ticagrelor and atorvastatin in rats with Qi deficiency and blood stasis syndrome.
Topics: Animals; Atorvastatin; Cardiotonic Agents; Coronary Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drugs, Chinese Herbal; Male; Qi; Rats; Rats, Sprague-Dawley; Ticagrelor | 2020 |
Effects of atorvastatin and ticagrelor combination therapy on renal function and the levels of suppression of tumorigenicity 2 and interleukin-33 in patients with ST-segment elevation myocardial infarction.
Topics: Atorvastatin; Humans; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Percutaneous Coronary Intervention; Retrospective Studies; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome | 2020 |